Cartesian Therapeutics, Inc. (RNAC)
7.73
-0.17
(-2.15%)
USD |
NASDAQ |
Dec 10, 14:22
Cartesian Therapeutics Total Assets (Quarterly): 372.68M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Repligen Corp. | 2.924B |
| Cabaletta Bio, Inc. | 189.76M |
| Arcellx, Inc. | 655.92M |
| NovaBay Pharmaceuticals, Inc. | 3.487M |
| Palatin Technologies, Inc. | 8.615M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 408.52M |
| Shareholders Equity (Quarterly) | -35.84M |
| Debt to Equity Ratio | -0.3516 |
| Current Ratio | 10.67 |
| Net Debt Paydown Yield | -0.16% |